Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04911842 · ClinicalTrials.gov registry record
Midline Failures: A Comparison Between a Hydrophilic Biomaterial and Thermoplastic Polyurethane
A clinical trial of Midline Catheter, sponsored by Access Vascular.
- Completed
- Registry status
- 205
- Enrollment target
- 1
- Study location
NCT04911842: Completed study of Midline Catheter, sponsored by Access Vascular.
NCT04911842 is a study of Midline Catheter that has completed, run by Access Vascular. The registered enrollment target is 205 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04911842, a study of Midline Catheter, has completed, sponsored by Access Vascular.
- COMPLETED
- Registry status
- 205 participants
- Enrollment target
- 1
- Study location
Study Summary
Retrospective chart review to evaluate and compare the rate of failures between midlines made from different materials
Conditions Studied
Interventions
- DEVICE HydroMID
- DEVICE TPU
Study Locations (1)
Illinois
- Joseph Bunch - Romeoville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 205 participants |
| Start Date | 2021-05-20 |
| Est. Completion | 2022-01-18 |
What the finished NCT04911842 record still lists
NCT04911842 is an observational study that tracks outcomes without assigning an intervention. The registered 205 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Midline Catheter appearing as the primary indexed condition, and to 2 interventions - of which HydroMID is the first listed.
NCT04911842 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT04911842 about?
NCT04911842 is a clinical study titled "Midline Failures: A Comparison Between a Hydrophilic Biomaterial and Thermoplastic Polyurethane". Retrospective chart review to evaluate and compare the rate of failures between midlines made from different materials
What is the current status of trial NCT04911842?
This trial is currently completed. The enrollment target is 205 participants. The study started on 2021-05-20. Estimated completion is 2022-01-18.
What conditions does trial NCT04911842 study?
This clinical trial studies the following conditions: Midline Catheter.
What interventions are being tested in trial NCT04911842?
The interventions under investigation include: HydroMID (DEVICE), TPU (DEVICE).
Who is sponsoring clinical trial NCT04911842?
This trial is sponsored by Access Vascular, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04911842 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Midline Catheter
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03457493 · 205 participants · Phase 1
The University of Alabama At Birmingham (UAB) Neuroinflammation in Parkinson's Disease-TSPO- Positron Emission Tomography (PET) Substudy
- NCT05134857 · 205 participants · Phase 2
The Zonisamide and Reinforcement for Reducing Alcohol Use (ZARRA) Study
- NCT05181891 · 205 participants · Phase 2
Pharmaceutically-Enhanced Reinforcement for Reduced Alcohol and Smoking
- NCT05283811 · 205 participants · NA
Understanding Prefrontal and Medial Temporal Neuronal Responses to Algorithmic Cognitive Variables in Epilepsy Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI